# MarraBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/marrabio

- Industry: Biotechnology
- Headquarters: Newcastle upon Tyne, UK
- Website: www.marrabio.co.uk
- Total disclosed funding: $0.6M
- Latest round: Seed (Sep 1, 2023)
- Investors on record: 4

## About

Based in Tyne and Wear, UK, and founded in 2022, MarraBio Ltd., a.k.a. MarraBio designs, engineers, and constructs bacterial protein polymers comprising biological signals required for healthy cell growth, division, and behavior. In September 2023, MarraBio Ltd. raised seed funding from CPI, Maven Capital Partners, Northstar Ventures, and TCS Biosciences Ltd. As of September 2023, Dr. Daniel Peters is the CEO of the company.

The company provides proteins, such as Caf1, that mimic the function of conventional proteins in application across biomedical research and therapy, as well as the production of cultivated meat sectors.

MarraBio plans to use its proceeds from September 2023 funding to accelerate the creation of new drugs and increase the viability of animal-free meat production on a commercial scale.

## Funding rounds

- Seed, Sep 1, 2023, $0.6M — Northstar Ventures, CPI, TCS Biosciences Ltd, Maven VCT

## Investors

- Northstar Ventures (https://capitalatlas.ai/funds/northstar-ventures) — Seed
- CPI — Seed
- TCS Biosciences Ltd — Seed
- Maven VCT — Seed